IRON
IRON
NASDAQ · Biotechnology

Disc Medicine Inc

Mid-Cap Stocks Biotech Stocks Healthcare Stocks
$70.45
-0.35 (-0.49%)
As of Jun 23, 9:59 PM ET ·
Analyst Consensus
Strong Buy
19
Analysts
High
Coverage
Buy 18 95%
Hold 1 5%
Sell 0 0%
Price Target
Analyst Price Target -68.1% upside
Low Target $15.33
Average Target $22.47
High Target $35.88
Current Price $70.45
Current
$70.45
Target
$22.47
$15.33 $22.47 avg $35.88
Scenario Analysis
Bear Case
$15.33
-78.2%
Low target
Base Case
$22.47
-68.1%
Avg target
Bull Case
$35.88
+-49.1%
High target
Risk/Reward
0.6x
Unfavorable
Price in Context
52-Week High
$99.50
-29.2% from high
52-Week Low
$40.00
+76.1% from low
50-Day SMA
$78.91
-10.7% vs SMA
200-Day SMA
$68.08
+3.5% vs SMA
RSI (14)
34.9
Neutral
Target vs 52W High
$22.47
-77.4% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 40 78% $257.58 +9.7%
AMGN
Amgen Inc
 Hold 44 50% $190.87 -45.0%
GILD
Gilead Sciences Inc
 Strong Buy 39 82% $362.68 +190.0%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 40 83% $438.34 -6.4%
REGN
Regeneron Pharmaceuticals
 Buy 38 71% $76.80 -87.6%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 37 76% $102.31 -64.5%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -32.7%
NTRA
Natera Inc
 Strong Buy 27 89% $142.91 -39.1%